The Irish Haemophilia Society (IHS) welcomed publication of the Lindsay Report today, but said it highlights the failure of State agencies in relation to the haemophilia community in Ireland.
"This failure had tragic consequences which are highlighted in detail," said Mr Brian O'Mahony, chairman of the IHS.
Mr O'Mahony said it is apparent that there was serious "lack of communication" and "bad decision making" on the part of the agencies.
From initial examination he said that in particular the report is critical of the actions and policies of the Blood Transfusion Service Board (BTSB) (now the Irish Blood Transfusion Service Board), in relation to the treatment and care of haemophilia sufferers.
The BTSB should "fully look and appreciate that they made mistakes and not make them again in the future," said Mr O'Mahony. "The state needs to learn from this and ensure that the catastrophic failures that led to deaths are not repeated".
One of the most significant findings he said is that the BTSB failed to heat-treat Factor IX and withdraw non-heat treated Factor IX, which led to the infection of seven hemophilia sufferers with HIV and the subsequent death of five people.
IHS administrator Ms Rosemany Daly added "the report finds that the views of the Department of Health were based on incomplete and inaccurate information in relation to HIV and Factor IX".
Ms Daly said that the IHS's legal team is going through the report and will have further comment on the decision not to send the report to the Director of Public Prosecution in due course.
The IHS also reiterated its call for a full inquiry into the role of pharmaceutical companies in the infection of haemophilia sufferers with HIV and Hepatitis C through contaminated blood products.
"These questions remain unanswered," Ms Daly said. "The IHS calls on the Minister for Health to ensure that the facts surrounding the pharmaceutical companies emerge through a full and rigorous inquiry at a future date".